Welcome to PsychU!

Virtual Event – Psychedelics For The Treatment Of Depression: Focus On 5HT-2A

Loading Events

Virtual Event – Psychedelics For The Treatment Of Depression: Focus On 5HT-2A

The presenters will discuss the history of psychedelics in therapeutic approaches with a primary focus on psilocybin. They will also review the neurobiology of psychedelics and the role of 5-HT2A receptors, review the results of recently published findings, and discuss the challenges associated with psychedelic-assisted therapies.

Featuring

  • Philip G. Janicak, MD

    Adjunct Professor and Consultant to the Therapeutic Neuromodulation Program in the Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine and a Distinguished Life Fellow in the American Psychiatric Association

  • Rachel Self, PhD, MS (OPDC)

    Medical Science Director, Neuroscience Field Medical Affairs

Philip G. Janicak, MD is a consultant for Otsuka Pharmaceutical Development & Commercialization, Inc. Rachel Self, PhD, MS is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.rn

Register

This event registration is closed.

Join today for instant access to all PsychU content, events, and more!

Membership is free!

Join PsychU Today to receive a wide array of tools and benefits

  • Join our multidisciplinary community that is improving mental health care… together
  • Quickly learn more about the topics you're interested in
  • Access an award-winning library of on-demand mental health resources
  • Gain key insights from industry expert & thought leaders